Centrexion Therapeutics' Convertible Note - II Round

Centrexion Therapeutics raised a round of funding on April 15, 2016.

Centrexion Therapeutics is focused on developing new treatments for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.…

Articles about Centrexion Therapeutics' Convertible Note - II Round: